Evaluating the effectiveness of different topical anesthetic methods in reducing pain during intravitreal injections: a systematic review and meta-analysis
Authors:
- Renad Alhomidi AlmotiriRARenad Alhomidi Almotiri
- Zahraa Hussain AlsaggafZAZahraa Hussain Alsaggaf
- Yara Hamed AbosabaahYAYara Hamed Abosabaah
- Sadeem Saad Abdulaziz AlkalufSASadeem Saad Abdulaziz Alkaluf
- Rana Ali A. AlgahamdiRARana Ali A. Algahamdi
- Ali Mousa Ahmed AlkhalafAli Mousa Ahmed Alkhalaf
- Ayah Mazen KurdiAKAyah Mazen Kurdi
- Ishraq Tail AlkhudaidiIAIshraq Tail Alkhudaidi
- Sarah Husam AlJefriSASarah Husam AlJefri
Open Access
- 30 June 2026
- journal article
- review article
- Published by Springer Nature in International Journal of Retina and Vitreous
- Vol. 12 (1)
Abstract
Background: The rapid rise in intravitreal injections (IVIs) for vitreoretinal disorders underscores the need to optimize the procedure and support long-term patient compliance. Patient-reported pain and discomfort remain significant barriers to adherence. This systematic review evaluates the efficacy and safety of various local anesthetic methods for mitigating pain during IVIs. Methods: Conducted in accordance with PRISMA guidelines, a comprehensive search of PubMed and Google Scholar was performed to identify English-language randomized controlled trials (RCTs). Eligible studies included patients aged 18 years and older receiving local anesthesia for IVIs, where pain was quantified using standard visual or oral analog scales (0–10 or 0–100). Results: Our systematic review and meta-analysis included 14 RCTs comprising 1,300 patients. Analysis of topical lidocaine, tetracaine, and proparacaine formulations showed comparable analgesic efficacy, with all agents consistently achieving mild mean Visual Analog Scale (VAS) pain scores. No clinically meaningful superiority was identified among these primary agents ( p = 0.62). Adjunctive therapies, particularly physical cooling (e.g., ice patches), demonstrated significant pain-reducing potential. While oxybuprocaine alone was less effective, its combination with physical cooling achieved the lowest mean pain scores. Meanwhile, topical NSAIDs showed limited additional benefit. Regarding safety, subconjunctival anesthetic injections were associated with a significantly higher incidence of subconjunctival hemorrhage and chemosis compared to topical applications, suggesting that topical strategies provide a favorable safety and efficacy profile for routine intravitreal injections. Conclusion: In conclusion, this systematic review and meta-analysis confirms that no single topical anesthetic is superior for intravitreal injections; all primary agents provide comparable, effective pain control. Topical application is safer than subconjunctival injection, which is associated with higher rates of hemorrhage and chemosis. Consequently, clinical protocols should standardize low-risk topical methods and incorporate simple non-pharmacological adjuncts, such as physical cooling, to optimize patient comfort.Keywords
Funding Information
- Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU-DDRSP2601)
This publication has 24 references indexed in Scilit:
- Safety and efficacy of various topical anesthesia for intravitreal injection: a randomized controlled trialInternational Ophthalmology, 2026
- Effect of Needle Gauge Size on Pain During Intravitreal Anti-VEGF Injection: A Systematic Review and Network Meta-AnalysisOphthalmology and Therapy, 2024
- Intravitreal injections: past trends and future projections within a UK tertiary hospitalEye, 2021
- Control of Pain in Intravitreal Injections: Evaluation of Combination Topical Anesthetics and Non-steroidal Anti-inflammatory DropsOphthalmology Retina, 2021
- Real-World Trends in Intravitreal Injection Practices among American Retina SpecialistsOphthalmology Retina, 2019
- Evolution of Intravitreal Therapy for Retinal Diseases—From CMV to CNV: The LXXIV Edward Jackson Memorial LectureAmerican Journal of Ophthalmology, 2018
- Analgesic Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections: A Randomized Crossover StudyCurrent Eye Research, 2018
- Effect of Ketorolac 0.5% Drops on Patients' Pain Perception During Intravitreal Injection ProcedureJournal of Ocular Pharmacology and Therapeutics, 2012
- Intravitreal Injection Anesthesia—Comparison of Different Topical Agents: A Prospective Randomized Controlled TrialAmerican Journal of Ophthalmology, 2011
- LIDOCAINE GEL ANESTHESIA FOR INTRAVITREAL DRUG ADMINISTRATIONRetina, 2005